All Stories

  1. Standardized processing of explanted hearts after stereotactic arrhythmia radiotherapy (Bio-STAR): a STOPSTORM framework and first human findings
  2. Great debate: the new risk factor–weighted clinical likelihood model is useful to estimate the initial pre-test probability of obstructive coronary artery disease in individuals with suspected chronic coronary syndromes
  3. Elevating Practice
  4. Vascular access and closure management for electrophysiological interventions in 2025: a Clinical Consensus Statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the...
  5. Comparison of Single- vs. Dual-Lead CIEDs Regarding Perioperative Complications-Analysis of the Quality Assurance Data of the State of North Rhine-Westphalia, Germany
  6. Treatment of oesophageal perforation with through-the-scope clips post-high-power short-duration atrial fibrillation ablation: case report
  7. Incidence and predictors of thermal oesophageal and vagus nerve injuries in Ablation Index-guided high-power-short-duration ablation of atrial fibrillation: a prospective study
  8. P-wave duration as a marker of atrial remodeling in patients referred to ablation for atrial fibrillation: A new stratification tool emerging?
  9. Patient perspectives on same-day discharge following catheter ablation for atrial fibrillation: results from a patient survey as part of the monocentric FAST AFA trial
  10. P-wave duration and atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis
  11. Premature ventricular complexes from a left ventricular diverticulum: a case report
  12. Biatrial volume ratio predicts low voltage areas in atrial fibrillation
  13. Association of low-voltage areas with the regional wall deformation and the left atrial shape in patients with atrial fibrillation: A proof of concept study
  14. Predictors of rhythm outcomes after cardiac resynchronization therapy in atrial fibrillation patients: When should we use an atrial lead?
  15. Left atrial activation and asymmetric anatomical remodeling in patients with atrial fibrillation: The relation between anatomy and function
  16. A case of successful ablation of ventricular ectopic focus from the superior tricuspid annulus through the internal jugular vein: a case report
  17. Investigating relationships between left atrial volume, symmetry, and sphericity
  18. Association between peripheral plasma markers and left atrial anatomy in patients with atrial fibrillation
  19. Electrical storm in patients with implantable cardioverter-defibrillator in the era of catheter ablation: Implications for better rhythm control
  20. Cardiogenic Stroke Despite Low CHA2DS2-VASc Score: Assessing Stroke risk by Left Atrial Appendage Anatomy (ASK LAA)
  21. Differences in predictors of implantable cardioverter-defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies
  22. Comparison of left atrial dimensions in CT and echocardiography as predictors of long-term success after catheter ablation of atrial fibrillation
  23. Impact of asymmetrical dilatation of the left atrium on the long-term success after catheter ablation of atrial fibrillation
  24. Fast atrial activity predicts recurrence of atrial fibrillation after pulmonary vein isolation: results from a prospective randomized study
  25. Left atrial appendage morphology and thromboembolic risk after catheter ablation for atrial fibrillation
  26. Diagnosis and Management of Atrial Fibrillation: An Overview
  27. Precordial electrode placement for optimal ECG monitoring: Implications for ambulatory monitor devices and event recorders
  28. Impact of left atrial appendage morphology on peri-interventional thromboembolic risk during catheter ablation of atrial fibrillation
  29. IMPACT OF LEFT ATRIAL APPENDAGE MORPHOLOGY ON PER-INTERVENTIONAL THROMBOEMBOLIC RISK DURING CATHETER ABLATION OF ATRIAL FIBRILLATION
  30. Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function: The importance of rhythm and rate control
  31. Impact of single atrial fibrillation catheter ablation on implantable cardioverter defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies
  32. Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations
  33. Comparison of Dabigatran and Uninterrupted Warfarin in Patients With Atrial Fibrillation Undergoing Cardiac Rhythm Device Implantations
  34. Prolonged Ablation on Critical Segments of Pulmonary Vein Ostia in Paroxysmal Atrial Fibrillation: A Prospective Randomized Controlled Study
  35. To the Editor—Differentiation of orthodromic reciprocating tachycardia from atrioventricular nodal reentrant tachycardia
  36. Predictive value of left atrial volume measured by non-invasive cardiac imaging in the treatment of paroxysmal atrial fibrillation
  37. Oxygen Kinetics and Heart Rate Response during Early Recovery from Exercise in Patients with Heart Failure
  38. A Narrow QRS Tachycardia with Irregular Atrial and Ventricular Intervals and VA Dissociation: What Is the Mechanism?
  39. Characteristic changes of volume and three-dimensional structure of the left atrium in different forms of atrial fibrillation: predictive value after ablative treatment
  40. Intraprocedural Imaging of Left Atrium and Pulmonary Veins: A Comparison Study between Rotational Angiography and Cardiac Computed Tomography
  41. A Novel Cryoballoon Technique for Mapping and Isolating Pulmonary Veins: A Feasibility and Efficacy Study
  42. Optimal fluoroscopic projections for angiographic imaging of the pulmonary vein ostia: lessons learned from the intraprocedural reconstruction of the left atrium and pulmonary veins
  43. Reconstructing and Registering Three‐Dimensional Rotational Angiogram of Left Atrium during Ablation of Atrial Fibrillation
  44. Intraprocedural reconstruction of the left atrium and pulmonary veins as a single navigation tool for ablation of atrial fibrillation: A feasibility, efficacy, and safety study